18331-34-5
18331-34-5
Chemical Structure
BTR-1
- CAS No.: 18331-34-5
- Formula:C12H11NOS2
- Molecular Weight:249.35
IUPAC Name: (Z)-5-benzylidene-3-ethyl-2-thioxothiazolidin-4-one
InChIKey: ZQDPYAPUFMILTB-NTMALXAHSA-N
SMILES: S=C(N(CC)C/1=O)SC1=C/C2=CC=CC=C2
Biological Activity: BTR-1 is an active anti-cancer agent, causes S phase arrest, and affects DNA replication in leukemic cells. BTR-1 activates apoptosis and induces cell death[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BTR-1 | 99.96% | BTR-1 is an active anti-cancer agent, causes S phase arrest, and affects DNA replication in leukemic cells. BTR-1 activates apoptosis and induces cell death. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
BTR-1 (Standard) | ≥98% | BTR-1 (Standard) is the analytical standard of BTR-1 (HY-111617). This product is intended for research and analytical applications. BTR-1 is an active anti-cancer agent, causes S phase arrest, and affects DNA replication in leukemic cells. BTR-1 activates apoptosis and induces cell death. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
